BlackRock Investment Management, LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 107 filers reported holding THERAVANCE INC in Q2 2015. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$3,027,000
+46.9%
287,201
+0.1%
0.00%
+33.3%
Q3 2015$2,061,000
-60.9%
287,014
-1.6%
0.00%
-57.1%
Q2 2015$5,269,000
+46.3%
291,584
+27.2%
0.01%
+40.0%
Q1 2015$3,602,000
+12.3%
229,160
+1.1%
0.01%
+25.0%
Q4 2014$3,207,000
-17.6%
226,660
-0.5%
0.00%
-20.0%
Q3 2014$3,894,000
-42.4%
227,836
+0.3%
0.01%
-44.4%
Q2 2014$6,762,000
+682.6%
227,054
+713.0%
0.01%
+800.0%
Q1 2014$864,000
-9.8%
27,927
+3.9%
0.00%0.0%
Q4 2013$958,000
-8.4%
26,874
+5.0%
0.00%
-50.0%
Q3 2013$1,046,000
+9.2%
25,593
+2.9%
0.00%0.0%
Q2 2013$958,00024,8690.00%
Other shareholders
THERAVANCE INC shareholders Q2 2015
NameSharesValueWeighting ↓
Baupost Group 20,705,801$640,637,00015.48%
Litespeed Management, L.L.C. 1,931,554$59,762,0006.48%
Realm Partners LLC 323,121$9,997,0005.75%
Foundation Asset Management, LP 612,327$18,945,0005.15%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,937$86,816,0003.37%
Proxima Capital Management, LLC 513,500$15,888,0002.99%
IRIDIAN ASSET MANAGEMENT LLC/CT 6,955,078$215,190,0002.46%
SECTORAL ASSET MANAGEMENT INC 1,851,088$57,273,0002.36%
BB BIOTECH AG 888,244$27,482,0001.42%
Yakira Capital Management, Inc. 43,000$1,330,0001.19%
View complete list of THERAVANCE INC shareholders